Journal of the Korean Applied Science and Technology (한국응용과학기술학회지)

The Korean Society of Applied Science and Technology (한국응용과학기술학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of Obesity and Sarcopenia among COPD Patients in Korea

한국 COPD 환자의 비만도와 근감소증 분석

  • Jekal, Yoonsuk (Department of Physical Education, Jeju National University)
  • Received : 2020.06.07
  • Accepted : 2020.06.29
  • Published : 2020.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study is to analyze the level of obesity and sarcopenia among chronic obstructive pulmonary disease(COPD) patients in Korea. The current study recruited 75 patients with COPD who visited the department of respiratory medicine at J University Hospital in J-do. Height, body weight, waist circumference, and hip circumference were measured, and body composition, muscle strength, and flexibility were assessed. The levels of obesity were classified with body mass index(BMI), waist-hip circumference ratio(WHR) and percent body fat, and sarcopenia was classified with the value of skeletal muscle mass and muscle strength by Asian Working Group for Sarcopenia. In results, it was found that the level of obesity was very high as 43% by BMI, 88% by WHR, and 64% by percent body fat. The lower level of muscle strength was 15.50% in males and 23.50% in females. The lower level of muscle mass was 24.10% in males and .00% in females. Males who had one sarcopenia factors were 22.40%, and females were 23.50%, respectively. Males with sarcopenia were 6.90%, and females were .00%. In conclusion, regular resistance exercise is essential not only for the development of motor skills, but also for the normalization of skeletal muscle function and prevention of muscle dystrophy among COPD patients.

Keywords

References

  1. Teramoto S., "COPD pathogenesis from the viewpoint of risk factors", Intern. Med., Vol.46, No2, pp. 77-79,(2007). https://doi.org/10.2169/internalmedicine.46.1775
  2. Lopez-Campo J. L., Calero C., Quintana-Gallego E., "Symptom variability in COPD: a narrative review", Int. J. Chron. Obstruct. Pulmon. Dis., Vol.8, pp.231-238,(2013). https://doi.org/10.2147/copd.s42866
  3. Adeloye D., Chua S., Lee C., Basquill C., Papana A., Theodoratou E., Nair H., Gasevic D., Sridhar D., Campbell H., Chan K. Y., Sheikh A., Rudan I.; Global Health Epidemiology Reference Group (GHERG), "Global and regional estimates of COPD prevalence: Systematic review and meta-analysis", J. Glob. Health, Vol.5, No.2, pp.020415,(2015). https://doi.org/10.7189/jogh.05-020415
  4. Korean Centers for Disease Control and Prevention, "Korean Health Statistics 2016: The Seventh Korea National Health and Nutrition Examination Survey (KNHANES VII-1)", Retrieved December, 2017, from http://knhanes.cdc.go.kr/
  5. Korean Health Statistics, "Death-Cause Statistics 2015",(2016).
  6. Harris T., "Muscle mass and strength: relation to function in population studies", J. Nutr., Vol.127, Suppl.5, pp.1004S-1006S,(1997). https://doi.org/10.1093/jn/127.5.1004S
  7. Rosenberg H. I., "Sarcopenia: origins and clinical relevance", Clin. Geriatr. Med., No.3, pp.337-339,(2011). https://doi.org/10.1016/j.cger.2011.03.003
  8. Kenney W. L., Wilmore J., Costill D., "Physiology of Sport and Exercise 6th Edition", Human Kinetics,(2015).
  9. Cruz-Jentoft A. J., Baeyens J. P., Bauer J. M., Boirie Y., Cederholm T., Landi F., Martin F. C., Michel J., Rolland Y., Schneider S. M., Topinkova E., Vandewoude M., Zamboni M., European Working Group on Sarcopenia in Older People, "Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People", Age Ageing, Vol.39, No.4, pp.412-423,(2010). https://doi.org/10.1093/ageing/afq034
  10. Chen L., Liu L., Woo J., Assantachai P., Auyeung T., Bahyah K. S., Chou M., Chen L., Hsu P., Krairit O., Lee J. S. W., Lee W., Lee Y., Liang C., Limpawattana P., Lin C., Peng L., Satake S., Suzuki T., Won C. W., Wu C., Wu S., Zhang T., Zeng P., Akishita M., Arai H., "Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia", J. Am. Med. Dir. Assoc., Vol.15, No.2, pp.95-101,(2014). https://doi.org/10.1016/j.jamda.2013.11.025
  11. Mannino D. M., Thorn D., Swensen A., Holguin F., "Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD", Eur. Respir. J., Vol.32, No.4, pp.962-969,(2008). https://doi.org/10.1183/09031936.00012408
  12. Tselebis A., Pachi A., Ilias I., Kosmas E., Bratis D., Moussas G., Tzanakis N., "Strategies to improve anxiety and depression in patients with COPD: a mental health perspective", Neuropsychiatr. Dis. Treat., No.12, pp.297-328,(2016).
  13. Biskobing D. M., "COPD and osteoporosis", Chest, Vol.121, No.2, pp.609-620,(2002). https://doi.org/10.1378/chest.121.2.609
  14. Kim H. C., Lee G. D., Hwang Y. S., "Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease", Tuberculosis and Respiratory Diseases, Vol.68, No.3, pp.125-139,(2010). https://doi.org/10.4046/trd.2010.68.3.125
  15. Casaburi R., Gosselink R., Decramer M., Dekhuijzen R. P. N., Fournier M., Lewis M I., "Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society", Am. J. Respir. Crit. Care. Med., Vol.159, pp.S1-40,(1999).
  16. Maltais F., LeBlanc P., Jobin J., Casaburi R., "Peripheral muscle dysfunction in chronic obstructive pulmonary disease", Clin. Chest. Med., Vol.21, pp.665-677, (2000). https://doi.org/10.1016/S0272-5231(05)70176-3
  17. Gosker H. R., Wouters E. F., van der Vusse G. J., Schols A. M., "Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives", Am. J. Clin. Nutr., Vol.71, pp.1033-1047,(2000). https://doi.org/10.1093/ajcn/71.5.1033
  18. Franssen F. M., O'Donnell D. E., Goossens G. H., Blaak E. E., Schols A. M., "Obesity and the lung: 5. Obesity and COPD", Thorax. Vol.63, No.12, pp.1110-1117,(2008). https://doi.org/10.1136/thx.2007.086827
  19. Pitta F., Troosters T., Spruit M. A., et al., "Characteristics of physical activities in daily life in chronic obstructive pulmonary disease", Am. J. Respir. Crit. Care. Med., Vol.171, pp.972-977,(2005). https://doi.org/10.1164/rccm.200407-855OC